Search - tctmd.com

Displaying 561 - 580 of 883

Sort: Relevancy | Date

Presentation TCT 2017

What is the Optimal Therapy for Hypertension?

Presenter: Sidney C. Smith, Michael A. Weber

October 30, 2017

Presentation TCT 2017

New U.S. Hypertension Guidelines and Treatment Targets

Presenter: Sidney C. Smith, Michael A. Weber, Sandra J Taler

October 30, 2017

Presentation TCT 2017

Trial In the Pocket: Myheartcounts

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Alan C. Yeung

October 30, 2017

Presentation TCT 2017

Facebook and Twitter for Trial Recruitment: SCAD Case Example

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Jacqueline Saw

October 30, 2017

Presentation TCT 2017

Special Lunch Lecture: Radiation Safety in the Cath Lab - See Something, Say Something

Presenter: Stephen Balter

October 30, 2017

Presentation TCT 2017

Making the EHR Useful For Research: ADAPTABLE

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Adrian F Hernandez

October 30, 2017

Presentation TCT 2017

Keeping It Simple: Large Pragmatic Trials

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran

October 30, 2017

Presentation TCT 2017

The Inflammatory Hypothesis After CANTOS: CIRT

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

Clinical Research in the Cath Lab: Evolving Regulations and Implications for Patient Care

Presenter: Marian C. Hawkey, Tamim Nazif

October 30, 2017

Presentation TCT 2017

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

Should Alleviating ISCHEMIA Be the Goal?

Presenter: Bernard J. Gersh, Robert A. Harrington, David J. Moliterno

October 30, 2017

Presentation TCT 2017

Primary Prevention in High Risk Patients II: THEMIS

Presenter: Bernard J. Gersh, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Primary Prevention In High Risk Patients I: REPRIEVE

Presenter: Bernard J. Gersh, Robert A. Harrington, Pamela S. Douglas

October 30, 2017

Presentation TCT 2017

Valvular Heart Disease: Diagnosis and Treatment Options 2017

Presenter: Grzegorz L. Kaluza, Jose M. Wiley, Nicola Corvaja

October 29, 2017

Presentation

Mid- and Long-term Outcome Comparisons of Absorb BVS vs Everolimus-Eluting Stent

October 17, 2017

Presentation

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

October 17, 2017

Presentation

Association Between Use of Antithrombotic Medication and Hematuria-Related Complications

October 09, 2017

Presentation

High-Sensitivity Cardiac Troponin and Risk Stratification of Pts With Renal Impairment Presenting With Suspected ACS

October 06, 2017

Presentation CDM 2017

Can Heart Disease be Eventually Abolished? The PCSK9 Revolution

Presenter: Robert A. Vogel

October 06, 2017

Presentation

Coronary CT Angiography vs Functional Stress Testing for Patients With Suspected CAD

October 05, 2017

Advertisement

What is the Optimal Therapy for Hypertension?

New U.S. Hypertension Guidelines and Treatment Targets

Trial In the Pocket: Myheartcounts

Facebook and Twitter for Trial Recruitment: SCAD Case Example

Special Lunch Lecture: Radiation Safety in the Cath Lab - See Something, Say Something

Making the EHR Useful For Research: ADAPTABLE

Keeping It Simple: Large Pragmatic Trials

The Inflammatory Hypothesis After CANTOS: CIRT

Clinical Research in the Cath Lab: Evolving Regulations and Implications for Patient Care

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Should Alleviating ISCHEMIA Be the Goal?

Primary Prevention in High Risk Patients II: THEMIS

Primary Prevention In High Risk Patients I: REPRIEVE

Valvular Heart Disease: Diagnosis and Treatment Options 2017

Mid- and Long-term Outcome Comparisons of Absorb BVS vs Everolimus-Eluting Stent

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

Association Between Use of Antithrombotic Medication and Hematuria-Related Complications

High-Sensitivity Cardiac Troponin and Risk Stratification of Pts With Renal Impairment Presenting With Suspected ACS

Can Heart Disease be Eventually Abolished? The PCSK9 Revolution

Coronary CT Angiography vs Functional Stress Testing for Patients With Suspected CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content